| Specifications:: | 12.5mg*28 Capsules/bottle (box) | Indications: | Adult Patients With Thyroid Cancer, Renal Cell Carcinoma, Gastrointestinal Stromal Tumor, Solitary Fibrous Tumor, Hemangiopericytoma, Pancreatic Neuroendocrine Tumors, Thymoma, Thymic Carcinoma, Chordoma, Renal Cell Carcinoma, And Pancreatic Neuroendocrine |
|---|---|---|---|
| Target: | VEGFR-1,2,3 | Product Name: | Sunitinib |
| Recommended Dose: | Please Follow Doctor's Advice | Storage: | Please Store Below 25℃. Please Store In A Safe Place Out Of Reach And Sight Of Children! |
| Highlight: | Sunitinib 12.5,Sunitix 12.5 Sunitinib |
||
| Attribute | Value |
|---|---|
| Specifications | 12.5mg*28 capsules/bottle (box) |
| Target | VEGFR-1,2,3 |
| Recommended Dose | Please follow doctor's advice |
| Storage | Store below 25℃. Keep in a safe place out of reach and sight of children |
Sunitinib (pronounced sue-nit-i-nib) is a targeted cancer drug designed for specific therapeutic applications.